Lifeward (LFWD) Profit After Tax Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.39% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 30.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.38% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 6.53% |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn | -35.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.71% |
| Dec 31, 2025 | -0.22% |
| Sep 30, 2025 | 16.58% |
| Jun 30, 2025 | -13.86% |
| Mar 31, 2025 | -3.34% |
| Dec 31, 2024 | -58.21% |
| Sep 30, 2024 | -4.86% |
| Jun 30, 2024 | -11.07% |
| Mar 31, 2024 | -27.03% |
| Dec 31, 2023 | -24.18% |
| Sep 30, 2023 | -31.18% |
| Jun 30, 2023 | -17.59% |
| Mar 31, 2023 | -4.01% |
| Dec 31, 2022 | -14.12% |
| Sep 30, 2022 | -17.23% |
| Jun 30, 2022 | 1.04% |
| Mar 31, 2022 | -2.84% |
| Dec 31, 2021 | 8.39% |
| Sep 30, 2021 | 16.12% |
| Jun 30, 2021 | 18.48% |
| Mar 31, 2021 | 21.49% |
| Dec 31, 2020 | 21.82% |
| Sep 30, 2020 | 17.06% |
| Jun 30, 2020 | 23.23% |
| Mar 31, 2020 | 15.66% |
| Dec 31, 2019 | 25.21% |
| Sep 30, 2019 | 24.64% |
| Jun 30, 2019 | 20.46% |
| Mar 31, 2019 | 16.71% |
| Dec 31, 2018 | 12.56% |
| Sep 30, 2018 | 10.83% |
| Jun 30, 2018 | 0.06% |
| Mar 31, 2018 | -3.50% |
| Dec 31, 2017 | -3.93% |
| Sep 30, 2017 | -42.74% |
| Jun 30, 2017 | -49.56% |
| Dec 31, 2016 | -35.29% |
| Sep 30, 2016 | -34.23% |